Biopharma Quarterly Dealmaking Statistics, Q4 2016
A look at financing, M&A and alliance activity October–December 2016
Executive Summary
Biopharma companies closed out 2016 with $9.6 billion in financing, the strongest quarter of the year. M&A deals reached $12.2 billion in value, led by Lonza's takeover of Capsugel; most of the fourth quarter's largest partnerships were built around innovative platforms in antibodies, peptides and gene therapy.